Model for end-stage liver disease (MELD) exception for bacterial cholangitis

被引：22
|
作者：
Gores, Gregory J.
Gish, Robert G.
Shrestha, Roshan
Wiesner, Russell H.
机构：
[1] Calif Pacific Med Ctr, Dept Med, San Francisco, CA 94115 USA
[2] Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA 94115 USA
[3] Calif Pacific Med Ctr, Div Hepatol & Complex GI, Phys Fdn, San Francisco, CA 94115 USA
[4] Mayo Clin, Coll Med, Rochester, MN USA
[5] Piedmont Liver Transplantat Program, Atlanta, GA USA
来源：
LIVER TRANSPLANTATION | 2006年 / 12卷 / 12期
关键词：
D O I：
10.1002/lt.20966
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 50 条
  • [31] The Model for End-Stage Liver Disease (MELD) score predicts survival in patients with spontaneous bacterial peritonitis, and with ascites
    Malinchoc, M
    Gines, P
    Navasa, M
    Fernandez, J
    Kim, WR
    Wiesner, RH
    Kamath, PS
    GASTROENTEROLOGY, 2001, 120 (05) : A378 - A378
  • [32] Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception
    DuBrock, Hilary M.
    del Valle, Kathryn T.
    Krowka, Michael J.
    LIVER TRANSPLANTATION, 2022, 28 (07) : 1224 - 1230
  • [33] Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
    Raza, Muhammad H.
    Kwon, Yong
    Kobierski, Pierre
    Misra, Asish C.
    Lim, Angelina
    Goldbeck, Cameron
    Etesami, Kambiz
    Kohli, Rohit
    Emamaullee, Juliet
    LIVER TRANSPLANTATION, 2023, 29 (02) : 134 - 144
  • [34] Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list
    Ferraz-Neto, B. -H.
    Hidalgo, R.
    Thome, T.
    Melo, V. A., Jr.
    Lobue, A.
    Zurstrassen, M. P. V. C.
    Moraes, J. M., Jr.
    Meira-Filho, S. P.
    Rezende, M. B.
    Fonseca, L. E. P.
    Pandullo, F. L.
    Soeiro, F. S.
    Afonso, R. C.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (08) : 2511 - 2513
  • [35] A systematic review of the performance of the Model for End-Stage Liver Disease (MELD) in the setting of liver transplantation
    Cholongitas, Evangelos
    Marelli, Laura
    Shusang, Vibhakorn
    Senzolo, Marco
    Rolles, Keith
    Patch, David
    Burroughs, Andrew K.
    LIVER TRANSPLANTATION, 2006, 12 (07) : 1049 - 1061
  • [36] Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores
    Wronka, Karolina Maria
    Grat, Michal
    Stypulkowski, Jan
    Bik, Emil
    Krasnodebski, Maciej
    Masior, Lukasz
    Grat, Karolina
    Patkowski, Waldemar
    Krawczyk, Marek
    ANNALS OF TRANSPLANTATION, 2017, 22 : 251 - 256
  • [37] Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula
    Freeman, Richard B., Jr.
    Gish, Robert G.
    Harper, Ann
    Davis, Gary L.
    Vierling, John
    Lieblein, Leslie
    Klintmalm, Goran
    Blazek, Jamie
    Hunter, Robert
    Punch, Jeffrey
    LIVER TRANSPLANTATION, 2006, 12 (12) : S128 - S136
  • [38] Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era
    Mandell, MS
    LIVER TRANSPLANTATION, 2004, 10 (10) : S54 - S58
  • [39] Model for End-stage Liver Disease (MELD) as a Predictor of Post-Transplant Survival
    Patel, Jigar
    Huang, Chun-Chih
    Taefi, Amir
    Lalos, Alexander T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S356 - S356
  • [40] Model for end-stage liver disease score and MELD exceptions: 15 years later
    Asrani, Sumeet K.
    Kamath, Patrick S.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 346 - 354
12345